Revvity (RVTY) Stock Rises 0.48% to $158.77, Up 10.73% YTDRevvity (RVTY) up 0.48%—US$158.77—2026 stock snapshot, market cap $17.6B, 10‑73% YTD gain, biotech‑health tech insights.REVVITY INCUnited States Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Elliot Mercer 24/10/2026, 01:58 One minute to read
Revvity (RVTY) Climbs 9.3% in 30 Days, Outperforms Peers & Stays Above 200‑Day SMARevvity’s steady climb—up 9% in a month—shows how its multi‑omics tech and predictive diagnostics keep investors bullish amid biotech’s data‑driven shift.REVVITY INCUnited States Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Samantha Roth 22/10/2026, 14:43 3 minutes to read
Revvity Stock Slides 1.1% as Market Tilt Pressures Health‑Science ValuationsRVTY shares drop 1.1% as investors weigh Revvity’s high‑valuation risk and market‑wide sell‑off, questioning the firm’s future growth momentum.REVVITY INCUnited States Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Vanessa Liu 21/10/2026, 07:50 3 minutes to read